Page last updated: 2024-08-17

aldosterone and evacetrapib

aldosterone has been researched along with evacetrapib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beyer, TP; Cannady, EA; Cao, G; Chen, YQ; Cockerham, SL; Fields, T; Karathanasis, SK; Mantlo, NB; Schmidt, RJ; Zhang, Y; Zimmerman, KM	1
Brennan, DM; Kumar, A; Lincoff, AM; McErlean, E; Menon, V; Nicholls, SJ; Nissen, SE; Patel, DR; Riesmeyer, JS; Ruotolo, G; Weerakkody, G; Wolski, KE	1

Trials

1 trial(s) available for aldosterone and evacetrapib

Article	Year
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial. Journal of the American Heart Association, 2019, 12-03, Volume: 8, Issue:23 Topics: Aged; Aldosterone; Anticholesteremic Agents; Benzodiazepines; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Risk Assessment; Vascular Diseases	2019

Article

Year

Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial.

Journal of the American Heart Association, 2019, 12-03, Volume: 8, Issue:23

Topics: Aged; Aldosterone; Anticholesteremic Agents; Benzodiazepines; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Risk Assessment; Vascular Diseases

2019

Other Studies

1 other study(ies) available for aldosterone and evacetrapib

Article	Year
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure. Journal of lipid research, 2011, Volume: 52, Issue:12 Topics: Aldosterone; Animals; Benzodiazepines; Blood Pressure; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Humans; Male; Mice; Mice, Inbred NOD; Rats; Substrate Specificity	2011

Article

Year

Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure.

Journal of lipid research, 2011, Volume: 52, Issue:12

Topics: Aldosterone; Animals; Benzodiazepines; Blood Pressure; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Humans; Male; Mice; Mice, Inbred NOD; Rats; Substrate Specificity

2011